Ерибулин Ever Pharma

Eribulin is a chemotherapy medication used to treat certain cancers, including breast cancer and liposarcoma. It works by stopping cancer cells from dividing and spreading. This page provides neutral, factual details about eribulin for informational purposes only.

Eribulin is primarily used to treat metastatic breast cancer in patients who have previously received other chemotherapy treatments. It is also approved for the treatment of unresectable or metastatic liposarcoma in patients who have received prior chemotherapy. The medication is administered intravenously and is typically used when other treatments have not been effective.

Eribulin may cause side effects such as nausea, fatigue, or hair loss. Some patients experience changes in blood cell counts, which can increase the risk of infection or bleeding. It is important to monitor these effects closely during treatment. The medication may also cause peripheral neuropathy, which can include tingling or numbness in the hands and feet.

Eribulin should be handled with care, and proper safety measures should be taken during administration. Patients should inform their healthcare provider about any existing medical conditions, especially liver or heart problems. Regular blood tests are often required to monitor the body's response to the medication. Avoid contact with broken skin or mucous membranes.

Eribulin may interact with other medications, including strong CYP3A4 inhibitors or inducers, which can affect its effectiveness or increase side effects. Patients should inform their healthcare provider about all prescription, over-the-counter, and herbal medications they are taking. Alcohol and certain supplements may also interact with eribulin, so caution is advised.